SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-022208
Filing Date
2022-08-10
Accepted
2022-08-10 16:06:53
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aadi-20220630.htm   iXBRL 10-Q 1796073
2 EX-31.1 aadi-20220630xex311.htm EX-31.1 11342
3 EX-31.2 aadi-20220630xex312.htm EX-31.2 11186
4 EX-32.1 aadi-20220630xex321.htm EX-32.1 5961
5 EX-32.2 aadi-20220630xex322.htm EX-32.2 5647
  Complete submission text file 0001628280-22-022208.txt   6656652

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20220630.xsd EX-101.SCH 47537
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aadi-20220630_cal.xml EX-101.CAL 57910
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aadi-20220630_def.xml EX-101.DEF 177642
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20220630_lab.xml EX-101.LAB 555133
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20220630_pre.xml EX-101.PRE 347855
60 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20220630_htm.xml XML 880964
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 221151852
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences